Quantitative analysis of artificial intelligence-based detection of subregions from murine ear skin sections with application to quantifying drug-induced epidermal hyperplasia.
A systematic comparison of the performance of AI algorithms developed in HALO and Visiopharm shows that both HALO and Visiopharm algorithms have comparable performance and are resilient to training data size and changes in the color profile of the HE images.
Abstract
The advent of artificial intelligence (AI) technologies is creating a paradigm shift in drug discovery and development. Veterinary pathology is an area that can significantly benefit from AI tools. The availability of AI algorithms in commercial software packages such as HALO and Visiopharm has generated interest in automating pathologists' workflows for the detection and quantification of histology endpoints from whole-slide images. As each software package provides a distinct set of AI models, the relative performance and equivalency of these models for lesion detection and quantification are poorly understood. Here, we present a systematic comparison of the performance of AI algorithms developed in HALO and Visiopharm. Specifically, we trained AI algorithms in HALO and Visiopharm by using the same ground truth training data to detect different subregions and quantify their areas from hematoxylin and eosin (HE)-stained images of murine skin sections. We also calculate the performance metrics (precision, recall, F1 score) for each algorithm using the same test dataset. Our analysis shows that both HALO and Visiopharm algorithms have comparable performance and are resilient to training data size and changes in the color profile of the HE images. As an application, we compared the results of the AI algorithms against pathologists' scores to quantify epidermal hyperplasia. Our analysis shows that the quantitative data from AI algorithms are consistent with pathologists' scores. These results provide a quantitative characterization of commercially available AI models in HALO and Visiopharm and offer practical guidelines for designing and validating AI algorithms using these software packages.
Background: Accurate classification of Acute Lymphoblastic Leukemia (ALL) subtypes from peripheral blood smear (PBS) images using deep learning may support automated image-based analysis of this blood malignancy. Methods: We developed a custom lightweight Convolutional Neural Network (CNN) to classify white blood cells...
R. Abdallat, O. Al-Bataineh, A. Alqudah et al.· Italian National Conference...· 0 citations
An unsupervised, single-class anomaly detection approach based on a vision transformer architecture was developed to aid histopathology evaluation of rat liver from nonclinical toxicology studies. The approach was designed to detect any histopathology finding without requiring specific histopathology examples for train...
Thomas Forest, R. Amaravadi, Richard Baumgartner et al.· Toxicologic pathology (Print...· 0 citations
An automated algorithm is developed that quantifies lung health by calculating the proportion of affected versus healthy tissue through a pixel overlap comparison between segmented lung regions and detected lesions, and enables objective and reproducible assessments of pulmonary conditions from different anatomical per...
Alfredo Emanuel Pavón Pérez, Luis Felipe Marín Urias, Alejandro José Linares Díaz et al.· Austral journal of veterinar...· 0 citations
Background Superficial fungal infections present a growing threat to global public health. Traditional diagnostic techniques, including microscopy and culture, are time-consuming and subjective, often limiting diagnostic accuracy. Artificial intelligence (AI)-driven diagnostic tools offer a promising adjunct to improve...
Mei Liu, Wen-Jing He, Li-Nan Ni et al.· Frontiers in Cellular and In...· 0 citations
The analysis of histopathological images is an important method of diagnosing cancer. Deep learning models, such as convolutional neural networks and transformer-based models have demonstrated great potential in automated cancer detection. However, they are black-box and cannot be understood in a clinical context. In t...
Anandhi K., Krithiga T.· Indian Journal of Computer S...· 0 citations
The efficacy of candidate drugs for neuroprotection is tested in rodent models of retinal atrophy where light-induced outer retinal atrophy (ORA) is quantified by manual or semi-automated measurements, analyses that are time-consuming and error-prone. We developed a quantitative, automated image analysis-based method o...
Christiane V. Löhr, T. Lejeune, Lindsey A. Smith et al.· Veterinary Pathology-Supplem...· 0 citations
Is your company’s AI sovereign? A practical guide for CIOs on AI vendor lock-in, EU Data Act switching, cloud sovereignty, and testing your exit plan before you need it. The post Sovereignty Is the Option to Leave appeared first on GPT-Lab.
Microsoft Research Blog· microsoft.comOct 30, 2026
Evaluating Microsoft Copilot at enterprise scale requires test data that captures the full complexity of real organizations, yet real enterprise data contains sensitive information that cannot be used for evaluation under any circumstances. The post From synthetic enterprise data evaluations to real Microsoft Copilot AI confidence appeared first on Microsoft Research.
Microsoft Research Blog· microsoft.comOct 29, 2026
Host Sowbhagya Suresh shares some of the latest news and cutting-edge research from across Microsoft—from understanding the challenges facing coding agents to uncovering how people use AI at work and improving extended-range weather forecasting. The post Microsoft Research Focus – Edition #97 appeared first on Microsoft Research.
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.